Addiction:

More Info
Susan L. Andersen, PhD

Director, Laboratory of Developmental Neuropharmacology, McLean Hospital
Associate Professor of Psychiatry, Harvard Medical School

Laboratory of Developmental Neuropharmacology

More Info
Jack Bergman, PhD

Associate Professor of Psychobiology in the Department of Psychiatry, HMS

Behavioral Pharmacology Program

Mechanisms of substance abuse, abuse-related effects of stimulants, abuse liability of novel anxiolytics

More Info
Hans Breiter, MD

Co-Director, MGH Translational Center for Prescription Drug Abuse
Assistant Professor of Psychiatry, Harvard Medical School

Phenotype Genome Project

neural circuitry of aversive and reward processing; interface of pain and substance abuse; mathematical modeling, clinical phenotyping, structural and functional imaging, genetics

More Info
Joshua Buckholtz, PhD

Assistant Professor of Psychology, Harvard University

The Systems Neuroscience of Psychopathology Laboratory

Self control, reward systems and psychopathology

More Info
Elena Chartoff, PhD

Director, Neurobiology of Motivated Behavior Laboratory, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School

Chartoff Lab: Neurobiology of Motivated Behavior Laboratory

Molecular and behavioral techniques and focuses on the study of drug dependence

More Info
Hilary Smith Connery, MD, PhD

Clinical Director, Alcohol and Drug Abuse Treatment Program; Assistant Professor of Psychiatry

Alcohol and Drug Abuse Treatment Center

novel treatments for opioid dependence and co-morbid psychiatric and substance-use disorders

More Info
A. Eden Evins, M.D., M.P.H.

Associate Professor of Psychiatry, HMS

MGH, Director, Center for Addiction Medicine

discovery and development of novel pharmacologic and behavioral treatments for substance abuse

More Info
Shelly Greenfield, MD, MPH

Chief Academic Officer, McLean Hospital
Chief, Division of Women’s Mental Health, McLean Hospital
Director, Alcohol and Drug Abuse Clinical and Health Services Research Program, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Development of new treatments for patients with substance use disorders and innovating the integration of delivery of mental health and substance abuse treatment services into diverse settings

More Info
Staci Gruber, PhD

Director, Cognitive and Clinical Neuroimaging Core, McLean Hospital
Director, Marijuana Investigations for Neuroscientific Discovery, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School

Cognitive and Clinical Neuroimaging Core (CCNC)

neurocognitive batteries and neuroimaging techniques to better define the neurobiological correlates of substance use and psychiatric disorders, use of supplements to treat mild to moderate traumatic brain injuries

More Info
Kevin P. Hill, MD, MHS

Director, Substance Abuse Consultation Service, Division of Alcohol and Drug Abuse, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Substance use disorders (especially cannabis, alcohol, and opioids), smoking cessation

More Info
James Hudson, MD, ScD, SM

Director, Biological Psychiatry Laboratory, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Biological Psychiatry Laboratory

Alcohol and Drug Abuse Clinical Research Center

genetic epidemiology of eating disorders, mood disorders, fibromyalgia, personality disorders, and substance use disorders. Pharmacologic treatment studies for psychiatric disorders and pain syndromes.

More Info
Haiden A. Huskamp, PhD

Henry J. Kaiser Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School

Blavatnik Institute: Health Care Policy

More Info
John Kelly, Ph.D.

Director, Addiction Recovery Management Service (ARMS), MGH; Director, Recovery Research Institute, MGH; Associate Director, Center for Addiction Medicine, MGH; Elizabeth R. Spallin Associate Professor of Psychiatry in the Field of Addiction Medicine, HMS

Addiction Recovery Management Services

experimental and naturalistic studies that develop and test new treatments for individuals with substance use disorders

More Info
John Neumeyer, PhD

Director, Medicinal Chemistry Laboratory, McLean; Lecturer on Psychiatry, HMS

Medicinal Chemistry Laboratory

synthesis and development of medications for drug abuse and the synthesis of radioligands for PET and SPECT imaging agents for psychiatric and neurological disorders

More Info
Harrison W. Pope, MD

Pyschiatrist & Director, Biological Psychiatry Laboratory, McLean; Professor of Psychiatry, HMS

Biological Psychiatry Laboratory

eating disorders, mood disorders, anabolic-androgenic steroid abuse, and psychopharmacological treatment effectiveness.

Elizabeth T. Ryan, PhD

Director, Sleep Diagnostics and Treatment Laboratory, McLean Hospital
Associate Director, Behavioral Psychopharmacology Research Laboratory, McLean Hospital
Instructor in Psychiatry, Harvard Medical School

Research Gate Profile

More Info
Marisa M. Silveri, PhD

Director, Neurodevelopmental Laboratory on Addictions and Mental Health, McLean Hospital
Associate Professor of Psychiatry, Harvard Medical School

Neurodevelopment Laboratory on Addictions and Mental Health

More Info
Roger Weiss, MD

Chief, Division of Alcohol and Drug Abuse, McLean Hospital
Director, Alcohol and Drug Abuse Clinical Research Program, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Alcohol and drug abuse research